Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the permalink-manager domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/medpointepharma.com/wp-includes/functions.php on line 6260
Articles Archives - Page 7 of 8 - MedPonte Pharmaceuticals
Categories
Articles

MedPointe – Management 7

Prescribing Information Please click to view and download the Cold Symptom Relief Guarantee document (Adobe PDF)

Categories
Articles

MedPointe – Compliance

Our compliance program is designed to provide the structure in which we work, reflecting our established policy of compliance with applicable legal and regulatory requirements. Compliance Program Annual declaration of compliance To obtain written copies of our compliance program and our annual declaration of compliance, call (800 437-9528 Extension 2205)

Categories
Articles

MedPointe – Management

Paul R. Edick President & Chief Executive Officer; Board Director (732) 564-2323 pedick@medpointepharma.com View Bio Corey N. Fishman Executive Vice President & Chief Financial Officer (732) 564-2335 cfishman@medpointepharma.com View Bio Beth P. Hecht Executive Vice President, General Counsel and Secretary (732) 564-2211 bhecht@medpointepharma.com View Bio Chris Maltese Senior Vice President, Business Information and Analytics (732) […]

Categories
Articles

MedPointe – Management 1

James S. Burns Co-Founder James S. Burns, a co-Founder of MedPointe and former MedPointe President, retired from the Company in November 2003, after having served over MedPointe’s first two years as one of its principal executives. Prior to MedPointe’s completion of the leveraged buyout of the Healthcare Business of Carter-Wallace Inc., Mr. Burns was a […]

Categories
Articles

MedPointe – Media Contacts

Press inquiries should be directed to MedPointe 265 Davidson Ave., Suite 300 Somerset, NJ 08873-4120 (732) 564-2200 info@medpointepharma.com  

Categories
Articles

Meda Pharmaceuticals – Privacy Policy

Home About Products Niacin Pills to Pass a Drug Test Join Us Media Center Healthcare Professionals Contact Us Privacy Policy   MEDA PHARMACEUTICALS INC. PRIVACY POLICY Introduction Thank you for your interest in MEDA Pharmaceuticals Inc. We invite you to explore our websites and learn more about us and our products. As you do so, […]

Categories
Articles

MedPointe Pharmaceuticals: Cold & Cough Relief Products 5

Taking Care of Yourself When You’re Sick A cold usually lasts a few days to a week. Taking care of yourself during a cold can help you get better quicker. Drink plenty of fluids but avoid caffeine and alcohol Use a humidifier to moisten the air you breathe Vitamins or good old chicken soup may […]

Categories
Articles

About: Compliance

Business Development  |  Compliance  |  Pension       Our compliance program is designed to provide the structure in which we work, reflecting our established policy of compliance with applicable legal and regulatory requirements. Meda’s Compliance Program Annual Declaration of Compliance To obtain written copies of our compliance program and our annual declaration of compliance, call 855 281-3420 […]

Categories
Articles

MedPointe – Partnerships

The rapidly changing economics of the pharmaceutical industry demands that companies constantly reassess their product portfolios. MedPointe was founded specifically to work with pharmaceutical firms looking for a partner to help them get the most value from their product assets. There are many situations in which partnership can provide a compelling solution. Products that once […]

Categories
Articles

MedPointe – Optivar

For the treatment of itching associated with allergic conjunctivitis Optivar®(azelastine hydrochloride ophthalmic solution, 0.05%) is a sterile ophthalmic solution indicated for the treatment of itching of the eye associated with allergic conjunctivitis in adults and children 3 years of age and older. Visit Optivar.com For More Information